Other News To Note
• BiondVax Pharmaceuticals Ltd., of Nes Ziona, Israel, entered a partnership with Warren, N.J.-based MonoSol Rx LLC to develop an oral film formulation of BiondVax's universal flu vaccine, M-001, using MonoSol Rx's PharmFilm delivery platform. The collaboration will include studies using PharmFilm technology to investigate the activity and formulation of the influenza vaccine when delivered via an oral film. Financial terms were not disclosed.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Our address has changed:
BioWorld | 115 Perimeter Center Place
Suite: 1100 | Atlanta, Georgia 30346, USA
Suite: 1100 | Atlanta, Georgia 30346, USA
For Sales Inquiries,
http://ip-science.interest.thomsonreuters.com/Bioworld_Sales_Inquiry
NORTH AMERICA
Tel: +1 877.857.2477
Outside of the US
Tel. +44 203 684 1796
http://ip-science.interest.thomsonreuters.com/Bioworld_Sales_Inquiry
NORTH AMERICA
Tel: +1 877.857.2477
Outside of the US
Tel. +44 203 684 1796
Part of Thomson Reuters
Note: our contact information has changed
Customer Service:
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
http://ip-science.thomsonreuters.com/support/#open_a_support_case
Hours: Monday - Friday, 8:00am - 6:00 pm EST
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
http://ip-science.thomsonreuters.com/support/#open_a_support_case
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2014 Thomson Reuters. Reproduction, reposting content is strictly prohibited.
Free Ezine
Sign up for Highlights FREE e-mail newsletter